63 search results found
-
RD-11.15-16.2022-Capra-Biosciences
Beyond Sustainability: Distributed, Scalable Chemical Manufacturing Using Biology -
4.4.23-Health-Replay-Holdings
Reprogramming Biology by Writing and Delivering Big DNA -
Past Deadline: Oct 19, 2023
Seeking Startup Speakers for 2024 MIT Japan Conference in Tokyo
speakerMIT Startup Exchange is looking for 10 startups to present and exhibit at the MIT Japan Conference in Tokyo on Tuesday, January 23, 2024.
-
Past Deadline: Feb 11, 2022
2022 Sanofi Golden Ticket Competition for life science and biotech
partnershipSanofi is sponsoring an inaugural global Golden Ticket Competition that will award three promising startup companies a one-year pre-paid residence at one of three sponsored BioLabs sites.
-
Asimov, Inc.
Cambridge, MassachusettsAsimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More
-
BioBuilder
Natalie Kuldell, President, Founder, & Executive Director, BioBuilder Educational Foundation
-
Past Deadline: Feb 2, 2024
2024 MIT Health Science Technology Conference
speakerLooking for 8-10 startups to participate on April 10 in Lightning Talks and Lunch Exhibit at the 2024 MIT Health Science Technology Conference.
-
Vaxess Technologies, Inc.
Cambridge, MAVaxess Technologies is a venture-backed biotechnology company developing novel products based on its proprietary MIMIX microneedle delivery platform. Our lead program is a sustain-release flu microneedle patch. We also have a pipeline of undisclosed targets including mRNA, immun/ooncology and other... More
- Wed, April 10, 2024 | Conference
2024 MIT Health Science Technology Conference - Startup Exchange Lightning Talks
Boston Marriott CambridgeThe 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
